These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 25146438

  • 1. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of Roughness on the Dispersion of Dry Powders for Inhalation: a Dynamic Visualization Perspective.
    Kou X, Heng PWS, Chan LW, Wereley ST, Carvajal MT.
    AAPS PharmSciTech; 2019 Jul 30; 20(7):271. PubMed ID: 31363868
    [Abstract] [Full Text] [Related]

  • 7. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 8. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ, Worth Longest P, Hindle M.
    Int J Pharm; 2013 Feb 25; 443(1-2):137-45. PubMed ID: 23313343
    [Abstract] [Full Text] [Related]

  • 9. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
    Young PM, Wood O, Ooi J, Traini D.
    Int J Pharm; 2011 Sep 15; 416(1):129-35. PubMed ID: 21708238
    [Abstract] [Full Text] [Related]

  • 10. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW.
    Int J Pharm; 2006 Mar 09; 310(1-2):81-9. PubMed ID: 16442246
    [Abstract] [Full Text] [Related]

  • 11. Dissolution of fine particle fraction from truncated Anderson cascade impactor with an enhancer cell.
    Tay JYS, Liew CV, Heng PWS.
    Int J Pharm; 2018 Jul 10; 545(1-2):45-50. PubMed ID: 29689370
    [Abstract] [Full Text] [Related]

  • 12. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ, Jain RR, Soni PS, Abdul S, Darshana H, Gaikwad RV, Menon MD.
    J Aerosol Med Pulm Drug Deliv; 2015 Aug 10; 28(4):254-67. PubMed ID: 25517187
    [Abstract] [Full Text] [Related]

  • 13. Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers.
    Jetmalani K, Young PM, Smith T, Stewart P, Traini D.
    Drug Dev Ind Pharm; 2012 Dec 10; 38(12):1504-11. PubMed ID: 22335558
    [Abstract] [Full Text] [Related]

  • 14. Aerosolization behavior of carrier-free L-leucine coated salbutamol sulphate powders.
    Raula J, Lähde A, Kauppinen EI.
    Int J Pharm; 2009 Jan 05; 365(1-2):18-25. PubMed ID: 18789380
    [Abstract] [Full Text] [Related]

  • 15. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 15; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug 15; 27(4):279-89. PubMed ID: 24074143
    [Abstract] [Full Text] [Related]

  • 18. Influence of realistic inspiratory flow profiles on fine particle fractions of dry powder aerosol formulations.
    Martin GP, Marriott C, Zeng XM.
    Pharm Res; 2007 Feb 15; 24(2):361-9. PubMed ID: 17177114
    [Abstract] [Full Text] [Related]

  • 19. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A.
    Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739
    [Abstract] [Full Text] [Related]

  • 20. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K, Leuenberger H, Fueg LM, Müller-Walz R, Okamoto H, Danjo K.
    Yakugaku Zasshi; 2000 Jan 12; 120(1):113-9. PubMed ID: 10655787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.